logo
FDA sends warning to 5 sunscreen brands including Supergoop — why they could be pulled from shelves

FDA sends warning to 5 sunscreen brands including Supergoop — why they could be pulled from shelves

New York Post2 days ago
Some of the summer's hottest beauty products just got burned.
'Beware of sunscreen products in mousse form because they might not be effective,' the Food and Drug Administration cautioned in a post on X this week.
The alert follows a wave of warning letters the agency sent to Supergoop!, Vacation Inc. and three other popular brands, accusing them of peddling whipped, mousse and foam sunscreens that flout federal laws.
Advertisement
3 Mousse sunscreen may be popular, but the FDA says the product doesn't comply with federal laws regarding over-the-counter drugs.
Supergoop!
Before you send your beloved sunscreens packing, let's break down the FDA's warnings.
The letters — also sent to Kalani Sunwear, K & Care Organics and Fallien Cosmeceuticals (makers of TiZo sunscreen) — claim the frothy formulas are 'misbranded.'
That's because sunscreens are classified as over-the-counter drugs in the US — and that comes with strict regulations around how they're formulated and marketed.
Advertisement
Per FDA rules, sunscreens can only be sold as oils, lotions, creams, gels, butters, pastes, ointments, sticks, sprays or powders — not foams, mousses, or whips.
To use those formats legally, companies must submit a new drug application with sufficient data proving their safety and effectiveness.
'There are no FDA-approved applications in effect for your drug products,' the agency wrote.
Advertisement
3 Because they're marketed to prevent sunburns and skin cancer, sunscreens are regulated as drugs.
Vacation
The FDA also took aim at Vacation Inc.'s 'Classic Whip Sunscreen,' sold in containers that look like whipped cream cans and advertised as 'dessert for your skin.'
'Packaging drug products in containers that resemble food containers commonly used by adults and children can mislead consumers into mistaking the products for food, which is of particular concern as this increases the risk of accidental ingestion,' the agency warned.
Advertisement
But the FDA's heat doesn't necessarily mean these fluffy formulas fall short at blocking burns or reducing skin cancer risk.
'The letter does not state that mousse-format sunscreens are less effective or unsafe, nor does it question the quality or performance of our formulation,' Kalani Sunwear told Cosmetics Business, adding that it's 'Sun Mousse SPF 50 is developed and manufactured in Sweden to the highest European standards.'
A Supergoop! spokesperson told The Post that the warning 'is focused on product labeling and has nothing to do with its safety, effectiveness or formula,' and added that the company is 'working closely with the FDA to resolve this matter.'
3 To legally sell sunscreens in mousse, foam, or whipped form, companies have to file new drug applications, the FDA said.
TikTok/supergoop
Still, some outside experts aren't so sure about the whipped format.
'SPF is determined by applying 2 mg/cm^2, which is measured by weight, not volume,' Ava Perkins, a cosmetic chemist and US sunscreen expert, told The Cut.
'Because these mousse sunscreens have so much air incorporated into the product, it can be challenging to know if you're putting on enough, even if it seems like a lot is being dispensed,' she added.
Advertisement
The FDA's letters, dated August 6, gave each company 15 working days to explain how they plan to fix the issues or prove they're not in violation.
Kalani Sunwear has already started taking action, temporarily pulling its mousse-format sunscreen from its US website 'to ensure full compliance with the regulations,' according to CBS News.
The Post has reached out to Vacation, Kalani Sunwear, K & Care Organics and Fallien Cosmeceuticals for comment.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Radiopharm Theranostics Limited (RADX) Receives IND Approval From FDA To Initiate Phase I Therapeutic Clinical Study To Target B7H3 With Betabart (RV-01)
Radiopharm Theranostics Limited (RADX) Receives IND Approval From FDA To Initiate Phase I Therapeutic Clinical Study To Target B7H3 With Betabart (RV-01)

Yahoo

time3 hours ago

  • Yahoo

Radiopharm Theranostics Limited (RADX) Receives IND Approval From FDA To Initiate Phase I Therapeutic Clinical Study To Target B7H3 With Betabart (RV-01)

Radiopharm Theranostics Limited (NASDAQ:RADX) is among the 12 Best Australian Stocks to Buy Right Now. The company recently announced receiving Investigational New Drug (IND) approval from the FDA to begin a Phase 1 therapeutic clinical study to target B7H3 with Betabart (RV-01). A well-stocked pharmacy shelf full of the company's pharmaceuticals, nutraceuticals, over-the-counter medications, and health care products. The Lu-177-B7H3 monoclonal antibody is the first in class targeted radiopharmaceutical that is being developed against the 4lg type of B7H3. Radiopharm Theranostics Limited (NASDAQ:RADX) believes it has the potential to become a highly differentiated drug for treating individuals with aggressive solid tumors. The company says it is on track to initiate the first-in-human study during the fourth quarter of this calendar year. Findings from recent preclinical studies have shown that RV-01 exhibits hepatic clearance, which allows the isotope enough time to target tumors, while also potentially reducing adverse effects such as hematological toxicities. Moreover, these monoclonal antibodies are cleared by the liver, unlike peptides and small molecules. This, coupled with the shortened half-life of RV-01, makes this agent stand out compared to other monoclonal antibodies and targeted radiotherapeutics with a renal excretion pathway. Radiopharm Theranostics Limited (NASDAQ:RADX) is an Australia-based clinical-stage radiotherapeutics firm developing innovative radiopharmaceutical products for therapeutic and diagnostic applications in areas of high unmet medical need. While we acknowledge the potential of RADX as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: 11 Best Large Cap Defense Stocks to Buy According to Analysts and 10 Best Low Priced Defense Stocks to Buy Now. Disclosure: None. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

Incannex Healthcare Inc. (IXHL) Receives Positive Patient-Reported Outcomes For IHL-42X in Obstructive Sleep Apnoea
Incannex Healthcare Inc. (IXHL) Receives Positive Patient-Reported Outcomes For IHL-42X in Obstructive Sleep Apnoea

Yahoo

time3 hours ago

  • Yahoo

Incannex Healthcare Inc. (IXHL) Receives Positive Patient-Reported Outcomes For IHL-42X in Obstructive Sleep Apnoea

Incannex Healthcare Inc. (NASDAQ:IXHL) is among the 12 Best Australian Stocks to Buy Right Now. On August 8, the company announced positive new patient-reported outcomes from participants in its RePOSA Phase 2 trial of IHL-42X to treat obstructive sleep apnoea (OSA). A scientist in a lab coat examining a Petri dish containing a biopharmaceutical culture. The new insights were collected through exit interviews, in line with FDA's guidance on Patient-Focused Drug Development (PFDD). The results build on already compelling data to reinforce the potential of IHL-42X to improve sleep quality, cognitive function, and daily life. Incannex Healthcare Inc. (NASDAQ:IXHL) said that 57.6% of the respondents reported an improvement in their OSA, of which 89.5% described it as a meaningful change to their lives. Some of the reported benefits include better sleep quality, reduced sleepiness during the daytime, feeling fresh in the morning, and other cognitive and daily-life improvements. Joel Latham, President and CEO of Incannex Healthcare Inc. (NASDAQ:IXHL) stated the following on the findings: 'Our recent Phase 2 results for IHL-42X exceeded expectations. In some patients, we observed reductions in AHI of up to 83%, which is an extraordinary outcome and a powerful signal of the drug's potential. We believe the findings from the patient exit interviews underscore that these improvements are not just clinical—they are translating into meaningful, positive changes in patients' daily lives. This reinforces our belief that IHL-42X has the potential to significantly shift the treatment paradigm for OSA.' Incannex Healthcare Inc. (NASDAQ:IXHL) is a clinical-stage pharmaceutical company developing medicines to treat chronic conditions, including obstructive sleep apnea, generalized anxiety disorder, and rheumatoid arthritis. While we acknowledge the potential of IXHL as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: 11 Best Large Cap Defense Stocks to Buy According to Analysts and 10 Best Low Priced Defense Stocks to Buy Now. Disclosure: None. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

CVS, Target, Walmart: Which sell Plan B and/or the abortion pill?
CVS, Target, Walmart: Which sell Plan B and/or the abortion pill?

Miami Herald

time12 hours ago

  • Miami Herald

CVS, Target, Walmart: Which sell Plan B and/or the abortion pill?

Costco Wholesale has decided to not sell the abortion pill mifepristone across all its U.S. pharmacy stores, citing low demand. This isn't a change in policy or Costco (COST) dropping the medicine. It has never sold mifepristone in its warehouse clubs or through its pharmacies. "Our position at this time not to sell mifepristone, which has not changed, is based on the lack of demand from our members and other patients, who we understand generally have the drug dispensed by their medical providers," Costco said. The decision comes amid campaigns against the pill by religious activist groups, including Inspire Investing and Alliance Defending Freedom. Plan B (Levonorgestrel) Purpose: Emergency contraception to prevent pregnancy after unprotected sex or contraceptive failure (e.g., condom break). When used:Before a pregnancy starts, within 72 hours (best within 24 hours) after sex. How it works: Delays or prevents ovulation (egg release). May also prevent fertilization of the egg. Does not terminate an existing pregnancy. If the fertilized egg is already implanted, Plan B has no effect. Type: High-dose progestin (hormone), similar to birth control pill hormones, just in a single larger dose. Availability: Over-the-counter, no prescription, no age limit in the U.S. The Abortion Pill (Mifepristone + Misoprostol) Purpose: To end an existing pregnancy (up to about 10–11 weeks gestation in the U.S.). When used:After pregnancy has been confirmed (positive test or clinical confirmation). How it works:Mifepristone blocks progesterone, a hormone needed to maintain pregnancy. Misoprostol causes the uterus to contract and expel the pregnancy tissue. Type: Two different medications taken in sequence - not the same as hormonal birth control. Availability: Requires a prescription in the U.S. and is regulated under the FDA's Mifepristone REMS Program (dispensed at certified pharmacies, clinics, or by mail in states where legal). CVS: Stocked in most locations, typically in the family planning aisle; billing through insurance is possible, or pay out-of-pocket and claim later. You can also order online for Commonly available either on shelves or behind the counter; curbside and drive-thru pick-up may be offered Target: Carries Plan B both in-store and online, with options for delivery or same-day in-store Available in the family planning or sexual wellness section; online ordering with pickup or delivery options is also grocery and drugstore chains: Many large grocery store pharmacies (Kroger, Albertsons) and drugstore chains carry Plan B over-the-counter near other reproductive health retail pharmacies CVS and Walgreens: These two major chains have obtained FDA certification (through the Mifepristone REMS program) to dispense mifepristone in select locations, specifically in states where such dispensing is legally permitted. The list includes over 20 states such as California, New York, Illinois, Massachusetts, Pennsylvania, and others. However, availability varies by location and state-level restrictions Costco has said its decision on the abortion pill is a business one based on demand. The company generally stays out of politics. It has a very clear policy on its website: Costco Wholesale has a long-standing policy against making contributions to any political party or candidate, federal, state or local, in all countries in which we do business. This prohibition covers not only direct contributions, but also support through organizations created under section 527 of the Internal Revenue Code, buying tickets to political fundraising events, or furnishing goods, services, or equipment for political fundraising Company also prohibits contributions for "independent expenditures": communications that expressly advocate the election or defeat of a clearly identified candidate that are not made in cooperation, consultation, or concert with, or at the request or suggestion of, a candidate, candidate's authorized committee, or a political party. Related: Costco to keep abortion pill off shelves amid conservative outcry The Arena Media Brands, LLC THESTREET is a registered trademark of TheStreet, Inc.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store